findmyKOL
Clinical trialNCT01659099TerminatedPhase 3Interventional

GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma

SponsorThe Lymphoma Academic Research OrganisationEnrollment671Diffuse Large B Cell Lymphoma CD20 Positive
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

122 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium
  • Zna Stuivenberg

    Antwerp, Belgium

  • Hôpital Saint Joseph

    Arlon, Belgium

  • Rhms Baudour

    Baudour, Belgium

  • Az St Jan Brugge Oostende Av

    Bruges, Belgium

  • Chu Brugmann

    Brussels, Belgium

  • Clinique Universitaire Saint Luc

    Brussels, Belgium

  • Hôpital Erasme

    Brussels, Belgium

  • Institut Jules Bordet

    Brussels, Belgium

  • Chu de Charleroi

    Charleroi, Belgium

  • Grand Hôpital de Charleroi

    Charleroi, Belgium

  • Universitair Ziekenhuis Gent

    Ghent, Belgium

  • Ch Jolimont

    Haine-Saint-Paul, Belgium

  • Az Groeninge - Oncology Centre - Campus Maria'S Voorzienigheid

    Kortrijk, Belgium

  • Chr de la Citadelle

    Liège, Belgium

  • Chu de Liège - Clinique Saint Joseph

    Liège, Belgium

  • Chu de Liège -Domaine Sart Tilman

    Liège, Belgium

  • Chu Ambroise Paré

    Mons, Belgium

  • Clinique Saint Joseph -Hôpital de Warquignies

    Mons, Belgium

  • Clinique Sainte Elisabeth

    Namur, Belgium

  • Clinique Saint Pierre

    Ottignies, Belgium

  • Heilig Hart Ziekenhuis

    Roeselare, Belgium

  • Centre Hospitalier de Wallonie Picarde - Chwapi

    Tournai, Belgium

  • Ch de la Tourelle-Peltzer

    Verviers, Belgium

  • Université Catholique de Louvain Mont Godinne

    Yvoir, Belgium

France
  • Ch D'Abbeville

    Abbeville, France

  • Chu D'Amiens - Hôpital Sud

    Amiens, France

  • Chu D'Angers

    Angers, France

  • Ch Victor Dupouy

    Argenteuil, France

  • Ch D'Arras

    Arras, France

  • Ch D'Avignon

    Avignon, France

  • Hôpital de Bayonne - Chu de la Côte Basque

    Bayonne, France

  • Ch de Beauvais

    Beauvais, France

  • Chu de Besançon - Hôpital Jean Minjoz

    Besançon, France

  • Ch de Blois

    Blois, France

  • Aphp - Hôpital Avicenne

    Bobigny, France

  • Institut Bergonié

    Bordeaux, France

  • Polyclinique Bordeaux Nord Aquitaine

    Bordeaux, France

  • Ch Dr Duchenne

    Boulogne-sur-Mer, France

  • Ch Fleyriat

    Bourg-en-Bresse, France

  • Chu de Brest - Hôpital de Morvan

    Brest, France

82 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2012
Primary completion
31 Aug 2016
Completion
31 Dec 2017
Last update posted
7 Mar 2018
Registered enrollment
671
Registry id
NCT01659099

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.